Cleared Traditional

K200859 - Infinity M300

K200859 is an FDA 510(k) clearance for Infinity M300, manufactured by Draeger Medical Systems, Inc.. The device is a Class 2 Cardiovascular device with product code MHX cleared through the Traditional 510(k) pathway after a 149-day FDA review.

K200859 · Draeger Medical Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2020
Decision
149d
Days
Class 2
Risk

K200859 is an FDA 510(k) clearance for the Infinity M300. Classified as Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (product code MHX), Class II - Special Controls.

Submitted by Draeger Medical Systems, Inc. (Andover, US). The FDA issued a Cleared decision on August 28, 2020 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1025 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Draeger Medical Systems, Inc. devices

FDA 510(k) Submission Details - K200859

510(k) Number K200859 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2020
Decision Date August 28, 2020
Days to Decision 149 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
24d slower than avg
Panel avg: 125d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MHX Device Classification - Class 2, Special Controls

Product Code MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1025
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MHX Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms)

All 319
Devices cleared under the same product code (MHX) and FDA review panel - the closest regulatory comparables to K200859.
Monitor B125, Monitor B105
K201941 · Ge Medical Systems Information Technologies, Inc. · Nov 2020
Tempus Pro Patient Monitor
K201746 · Remote Diagnostic Technologies Limited · Sep 2020
IntelliVue Patient Monitor MX500, IntelliVue Patient Monitor MX550
K192137 · Philips Medizin Systeme Boeblingen GmbH · Sep 2020
ePM Series Patient monitors
K200015 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Jun 2020
Patient Monitor
K192972 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · May 2020
Patient Monitor
K192514 · Edan Instruments, Inc. · Apr 2020